Bausch Health Companies (BHC) Competitors $8.48 -0.28 (-3.20%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BHC vs. RDY, PCVX, CTLT, SRPT, QGEN, RVMD, ITCI, ROIV, ASND, and LEGNShould you be buying Bausch Health Companies stock or one of its competitors? The main competitors of Bausch Health Companies include Dr. Reddy's Laboratories (RDY), Vaxcyte (PCVX), Catalent (CTLT), Sarepta Therapeutics (SRPT), Qiagen (QGEN), Revolution Medicines (RVMD), Intra-Cellular Therapies (ITCI), Roivant Sciences (ROIV), Ascendis Pharma A/S (ASND), and Legend Biotech (LEGN). These companies are all part of the "pharmaceutical products" industry. Bausch Health Companies vs. Dr. Reddy's Laboratories Vaxcyte Catalent Sarepta Therapeutics Qiagen Revolution Medicines Intra-Cellular Therapies Roivant Sciences Ascendis Pharma A/S Legend Biotech Bausch Health Companies (NYSE:BHC) and Dr. Reddy's Laboratories (NYSE:RDY) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends, community ranking and institutional ownership. Does the media refer more to BHC or RDY? In the previous week, Dr. Reddy's Laboratories had 4 more articles in the media than Bausch Health Companies. MarketBeat recorded 4 mentions for Dr. Reddy's Laboratories and 0 mentions for Bausch Health Companies. Bausch Health Companies' average media sentiment score of 0.00 beat Dr. Reddy's Laboratories' score of -0.32 indicating that Bausch Health Companies is being referred to more favorably in the media. Company Overall Sentiment Bausch Health Companies Neutral Dr. Reddy's Laboratories Neutral Does the MarketBeat Community believe in BHC or RDY? Bausch Health Companies received 38 more outperform votes than Dr. Reddy's Laboratories when rated by MarketBeat users. Likewise, 61.47% of users gave Bausch Health Companies an outperform vote while only 59.55% of users gave Dr. Reddy's Laboratories an outperform vote. CompanyUnderperformOutperformBausch Health CompaniesOutperform Votes35961.47% Underperform Votes22538.53% Dr. Reddy's LaboratoriesOutperform Votes32159.55% Underperform Votes21840.45% Which has more risk and volatility, BHC or RDY? Bausch Health Companies has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Comparatively, Dr. Reddy's Laboratories has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Which has preferable valuation and earnings, BHC or RDY? Dr. Reddy's Laboratories has higher revenue and earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Dr. Reddy's Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBausch Health Companies$8.76B0.36-$592M-$0.48-17.67Dr. Reddy's Laboratories$299.87B0.04$668M$0.6322.49 Do analysts prefer BHC or RDY? Bausch Health Companies presently has a consensus price target of $7.75, indicating a potential downside of 8.61%. Dr. Reddy's Laboratories has a consensus price target of $17.00, indicating a potential upside of 19.97%. Given Dr. Reddy's Laboratories' higher probable upside, analysts plainly believe Dr. Reddy's Laboratories is more favorable than Bausch Health Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Dr. Reddy's Laboratories 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is BHC or RDY more profitable? Dr. Reddy's Laboratories has a net margin of 17.81% compared to Bausch Health Companies' net margin of -1.88%. Dr. Reddy's Laboratories' return on equity of 18.53% beat Bausch Health Companies' return on equity.Company Net Margins Return on Equity Return on Assets Bausch Health Companies-1.88% -755.86% 5.11% Dr. Reddy's Laboratories 17.81%18.53%13.01% Do institutionals & insiders have more ownership in BHC or RDY? 78.7% of Bausch Health Companies shares are held by institutional investors. Comparatively, 14.0% of Dr. Reddy's Laboratories shares are held by institutional investors. 8.1% of Bausch Health Companies shares are held by insiders. Comparatively, 2.0% of Dr. Reddy's Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryDr. Reddy's Laboratories beats Bausch Health Companies on 9 of the 16 factors compared between the two stocks. Ad Golden CrestBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide Get Bausch Health Companies News Delivered to You Automatically Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHC vs. The Competition Export to ExcelMetricBausch Health CompaniesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$3.12B$6.48B$5.12B$19.76BDividend YieldN/A8.13%5.18%3.50%P/E Ratio-17.675.6972.8137.06Price / Sales0.36349.551,250.2017.77Price / Cash1.2253.3440.7021.54Price / Book-12.859.606.454.64Net Income-$592M$154.43M$119.73M$982.94M7 Day Performance-9.21%-9.46%-5.13%-2.12%1 Month Performance1.37%-7.27%-2.71%-0.39%1 Year Performance22.90%28.13%31.08%23.34% Bausch Health Companies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHCBausch Health Companies2.7399 of 5 stars$8.48-3.2%$7.75-8.6%+29.3%$3.12B$8.76B-17.6720,270RDYDr. Reddy's Laboratories1.3454 of 5 stars$14.17-0.5%N/A+6.7%$11.83B$299.87B22.6427,048Analyst DowngradeShort Interest ↑PCVXVaxcyte3.3295 of 5 stars$86.83-6.3%N/A+73.3%$10.82BN/A-18.88160News CoverageHigh Trading VolumeCTLTCatalent2.8783 of 5 stars$59.10+0.3%N/A+48.7%$10.73B$4.38B-26.1516,900Analyst UpgradeInsider SellingNews CoverageSRPTSarepta Therapeutics4.9455 of 5 stars$104.54-4.2%N/A+26.0%$9.99B$1.64B83.631,314Analyst UpgradeQGENQiagen4.2892 of 5 stars$41.27-1.9%N/A+1.6%$9.42B$1.97B105.825,967Analyst RevisionRVMDRevolution Medicines3.5596 of 5 stars$55.13-3.9%N/A+159.4%$9.27B$11.58M-15.36443ITCIIntra-Cellular Therapies4.5093 of 5 stars$83.42-4.8%N/A+51.6%$8.84B$464.37M-95.88560Insider SellingPositive NewsROIVRoivant Sciences3.4226 of 5 stars$11.20-3.8%N/A+24.2%$8.28B$129.13M1.98860Analyst ForecastNews CoverageASNDAscendis Pharma A/S3.06 of 5 stars$126.51+1.8%N/A+35.3%$7.67B$288.08M-13.59640Analyst DowngradeShort Interest ↑News CoverageGap DownHigh Trading VolumeLEGNLegend Biotech1.8575 of 5 stars$38.19-4.3%N/A-39.9%$6.96B$455.99M-40.201,800Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoverageHigh Trading Volume Related Companies and Tools Related Companies Dr. Reddy's Laboratories Alternatives Vaxcyte Alternatives Catalent Alternatives Sarepta Therapeutics Alternatives Qiagen Alternatives Revolution Medicines Alternatives Intra-Cellular Therapies Alternatives Roivant Sciences Alternatives Ascendis Pharma A/S Alternatives Legend Biotech Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BHC) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
